The Use of Aromatherapy for Symptom Management
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02163369|
Recruitment Status : Unknown
Verified February 2015 by Central DuPage Hospital.
Recruitment status was: Recruiting
First Posted : June 13, 2014
Last Update Posted : February 4, 2015
The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety.
Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.
|Condition or disease||Intervention/treatment||Phase|
|Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients||Drug: Peppermint and Lavender Essential Oils||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||The Use of Aromatherapy for Symptom Management|
|Study Start Date :||July 2014|
|Estimated Primary Completion Date :||June 2015|
|Experimental: Peppermint and Lavender Essential Oils||
Drug: Peppermint and Lavender Essential Oils
- Post Intervention Patient Interview Form [ Time Frame: 24hrs post aromatherapy ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02163369
|Contact: Mary Lyons, MSN, APN/CNS, RN-BC, ONCemail@example.com|
|Contact: Lorraine Mack, MSN, RN, CNL, OCNfirstname.lastname@example.org|
|United States, Illinois|
|Central DuPage Hospital||Recruiting|
|Winfield, Illinois, United States, 60190|
|Contact: Mary Lyons, MSN, APN/CNS, RN-BC ONC 630-933-6011|
|Contact: Lorraine Mack, RN 630-933-3413|
|Principal Investigator:||Mary Lyons, MSN, APN/CNS, RN-BC, ONC||Central DuPage Hospital|